Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice
Authors:
- 23 January 2023
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 249, 115141
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Chongqing Municipal Education Commission
This publication has 36 references indexed in Scilit:
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNAScience, 2014
- In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutationsAntiviral Therapy, 2012
- Treatment of chronic hepatitis B with nucleos(t)ide analoguesHepatology Research, 2011
- Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJournal of Antimicrobial Chemotherapy, 2011
- Selection and Counterselection of the rtI233V Adefovir Resistance Mutation during Antiviral TherapyJournal of Clinical Microbiology, 2010
- Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assaysVirology Journal, 2009
- Benefits and risks of interferon therapy for hepatitis B #Hepatology, 2009
- The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packagingAntiviral Research, 2007
- Prevention of hepatitis B virus–related hepatocellular carcinomaGastroenterology, 2004
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003